European Medicines Agency-Committee for Advanced Therapies stakeholders workshop

  • Email
  • Help

Details

TitleEuropean Medicines Agency-Committee for Advanced Therapies stakeholders workshop
Date12/01/2012 - 12/01/2012
LocationEuropean Medicines Agency, London, UK
SummaryThis one-day workshop is organised by the Committee for Advanced Therapies (CAT) as part of its effort to strengthen the dialogue with its stakeholders. The main aim of the workshop is to communicate the outcome of focus group meetings held in 2011. Attendees will have the opportunity to send questions to the organising committee in advance.

All documents

Name Language First published Last updated
Agenda - Committee for Advanced Therapies stakeholders workshop (English only) 2011-11-30  
Programme - Focus groups: a model for a fruitful interaction between the Committee for Advanced Therapies and its stakeholders (English only) 2012-01-11  
Presentation - Committee for Advanced Therapies (CAT) interested parties focus groups: A new model for a fruitful interaction between CAT and its stakeholders (English only) 2012-02-02  
Presentation - Objectives of the focus group on non-clinical development of advanced-therapy medicinal products and outcome of discussions in 2011 (English only) 2012-02-02  
Presentation - Possible scenarios to address issues in non-clinical studies for advanced-therapy medicinal products (English only) 2012-02-02  
Presentation - Session 1: List of Questions from Participants on non-clinical development of ATMPs (English only) 2012-02-02  
Presentation - Focus group: a better system to navigate guidelines on advanced-therapy medicinal products (English only) 2012-02-02  
Presentation - Interactive flowchart for gene-therapy guidelines (English only) 2012-02-02  
Questions on session 2: Focus group 'better system to navigate advanced-therapy-medicinal-product guidance documents (English only) 2012-02-02  
Presentation - Committee for Advanced Therapies interested parties focus group 3 on incentives for academia, hospitals and charities: Objectives and outcome of the focus group meeting in 2011 (English only) 2012-02-02  
Presentation - Incentives for development of advanced-therapy medicinal products (English only) 2012-02-02  
Presentation - Improve certainty of regulatory outcome: An incentive identified by stakeholders to foster translation of research into commercial products: A small and medium-sized enterprise perspective (English only) 2012-02-02  
Presentation - Optimising resources (English only) 2012-02-02  
Presentation - Optimising resources: Incentives for academia, hospital and charities (English only) 2012-02-02  
Questions on session 3: Focus group 'incentives for academia, hospitals and charities developing advanced-therapy medicinal products' (English only) 2012-02-02  

Media Videos